GSK, Reed Smith Partner's Widow Preview Paxil Jury Trial

Law360, Chicago (March 9, 2017, 9:27 PM EST) -- An FDA-endorsed label change for antidepressants in 2007 didn’t go far enough to alert doctors about the increased risk of suicidality in patients taking GlaxoSmithKline’s Paxil, the widow of a deceased Reed Smith partner told an Illinois federal judge Thursday, offering a brief glance of what is to come at a jury trial next week.

U.S. District Judge William T. Hart asked counsel for GSK and Wendy Dolin to explain their liability theories surrounding the Paxil label that was available to prescribing physicians at the time that Dolin’s husband took his own life in 2010.

Wendy Dolin blames his death on...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!